Medical treatment of ectopic pregnancy: case report

Authors

  • Zaineb Chatbi Department of Gynecology and Obstetrics, Mohammed VI University Hospital, Oujda, Morocco
  • Soukaina Fekkoul Department of Gynecology and Obstetrics, Mohammed VI University Hospital, Oujda, Morocco
  • Inas Rhazi Department of Gynecology and Obstetrics, Mohammed VI University Hospital, Oujda, Morocco
  • Hafsa Tahiri Department of Gynecology and Obstetrics, Mohammed VI University Hospital, Oujda, Morocco
  • Hanane Saadi Department of Gynecology and Obstetrics, Mohammed VI University Hospital, Oujda, Morocco
  • Ahmed Mimouni Department of Gynecology and Obstetrics, Mohammed VI University Hospital, Oujda, Morocco

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20221299

Keywords:

Ectopic pregnancy, Methotrexate, β-hCG, Medical treatment of ectopic pregnancy

Abstract

Ectopic pregnancy occurs when the embryo implants outside the uterine cavity. It is a leading source of morbidity and mortality within pregnancy. Methotrexate, a folic acid antagonist, has been widely used to treat appropriately selected ectopic pregnancies. We report the case of a 20-year-old woman, married, G2P0, having as antecedent a right tubal ectopic pregnancy benefiting from a right salpingectomy two years ago, who presents actually a paucisymptomatic ectopic pregnancy. Medical treatment with methotrexate was chosen with monitoring of the patient's hemodynamic status and hCG level.

Metrics

Metrics Loading ...

References

Berg CJ, Chang J, Callaghan WM, Whitehead SJ. Pregnancy-related mortality in the United States, 1991–1997. Obstet Gynecol. 2003;101:289-96.

Hajenius PJ, Engelsbel S, Mol BW, Van der Veen F, Ankum WM, Bossuyt PM, et al. Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet. 1997;350:774-9.

Ankum WM, Mol BW, Van der Veen F, Bossuyt PM. Risk factors for ectopic pregnancy: a meta-analysis. Fertil Steril. 1996;65:1093-9.

Butts S, Sammel M, Hummel A, Chittams J, Barnhart K. Risk factors and clinical features of recurrent ectopic pregnancy: a case control study. Fertil Steril. 2003;80:1340-4.

Lipscomb GH, Stovall TG, Ling FW. Nonsurgical treatment of ectopic pregnancy. N Engl J Med. 2000;343:1325-9.

Rodi IA, Sauer MV, Gorrill MJ, Bustillo M, Gunning JE, Marshall JR et al. The medical treatment of unruptured ectopic pregnancy with methotrexate and citrovorum rescue: preliminary experience. Fertil Steril. 1986;46:811-3.

Calabresi P, Chabner BA. Antineoplastic agents. In: Gilman A, Goodman LS, Goodman A, eds. The pharmacologic basis of therapeutics. ed 8. New York: Macmillan Publishing. 1990:1275-6.

Barnhart K, Coutifaris C, Esposito M. The pharmacology of methotrexate. Expert Opin Pharmacother. 2001;2:409-17.

Stovall TG, Ling FW, Buster JE. Outpatient chemotherapy of unruptured ectopic pregnancy. Fertil Steril. 1989;51:435-8.

Ory SJ, Villanueva AL, Sand PK, Tamura RK. Conservative treatment of ectopic pregnancy with methotrexate. Am J Obstet Gynecol. 1986;1546:1299-306.

Pisarska MD, Carson SA, Buster JE. Ectopic pregnancy. Lancet. 1998;351:1115-20.

Fernandez H, Lelaidier C, Thouvenez V, Frydman R. The use of a pretherapeutic, predictive score to determine inclusion criteria for the non-surgical treatment of ectopic pregnancy. Hum Reprod. 1991;6:995-8.

Fernandez H, Pauthier S, Doumerc S, Lelaidier C, Olivennes F, Ville Y, et al. Ultrasound-guided injection of methotrexate versus laparoscopic salpingotomy in ectopic pregnancy. Fertil Steril. 1995;63:25-9.

Downloads

Published

2022-04-27

How to Cite

Chatbi, Z., Fekkoul, S., Rhazi, I., Tahiri, H., Saadi, H., & Mimouni, A. (2022). Medical treatment of ectopic pregnancy: case report. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 11(5), 1581–1584. https://doi.org/10.18203/2320-1770.ijrcog20221299

Issue

Section

Case Reports